Mind the gap in kidney care: Translating what we know into what we do

被引:0
|
作者
Luyckx, Valerie A. [1 ,2 ,3 ]
Tuttle, Katherine R. [4 ,5 ]
Abdellatif, Dina [6 ]
Correa-Rotter, Ricardo [7 ]
Fung, Winston W. S. [8 ]
Haris, Agnes [9 ]
Hsiao, Li-Li [2 ]
Khalife, Makram [10 ]
Kumaraswami, Latha A. [11 ]
Loud, Fiona [10 ]
Raghavan, Vasundhara [10 ]
Roumeliotis, Stefanos [12 ]
Sierra, Marianella [10 ]
Ulasi, Ifeoma [13 ]
Wang, Bill [10 ]
Lui, Siu-Fai [14 ]
Liakopoulos, Vassilios [12 ]
Balducci, Alessandro [15 ]
机构
[1] Univ Zurich, Epidemiol Biostat & Prevent Inst, Dept Publ & Global Hlth, Hirschengraben 84, CH-8001 Zurich, Switzerland
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Renal Div, Boston, MA 02115 USA
[3] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa
[4] Providence Inland Northwest Hlth, Providence Med Res Ctr, 105 W 8th Ave,Suite 250 E, Spokane, WA 99204 USA
[5] Univ Washington, Dept Med, Div Nephrol, Seattle, WA USA
[6] Cairo Univ, Dept Nephrol, Pediat Hosp, Cairo, Egypt
[7] Natl Med Sci & Nutr Inst Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City, DF, Mexico
[8] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Ninth Floor,Lui Che Woo Clin Sci Bldg,32 Ngan Shi, Hong Kong, Peoples R China
[9] Peterfy Hosp, Neurol Dept, Budapest, Hungary
[10] ISN, ISN Patient Liaison Advisory Grp, Brussels, Belgium
[11] Tamilnad Kidney Res Tanker Fdn, Chennai, Tamil Nadu, India
[12] Aristotle Univ Thessaloniki, AHEPA Hosp, Sch Med, Dept Nephrol 2, Thessaloniki, Greece
[13] Univ Nigeria, Coll Med, Dept Med, Ituku Ozalla, Enugu State, Nigeria
[14] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Hlth Syst Policy & Management, Shatin, Hong Kong, Peoples R China
[15] Italian Kidney Fdn, Rome, Italy
关键词
chronic kidney disease; equity; kidney care; public health; World Kidney Day; MIDDLE-INCOME; DISEASE; CKD; MANAGEMENT; MEDICINES; BARRIERS; OUTCOMES; BURDEN; RISK;
D O I
10.1111/jorc.12495
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.
引用
收藏
页码:79 / 91
页数:13
相关论文
共 50 条
  • [21] Health Disparities of Adults with Intellectual Disabilities: What Do We Know? What Do We Do?
    Krahn, Gloria L.
    Fox, Michael H.
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2014, 27 (05) : 431 - 446
  • [22] THE IMPACT OF DISASTERS ON HEALTH: WHAT DO WE KNOW? WHAT DO WE NEED TO KNOW?
    La Greca, A.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2012, 19 : S93 - S93
  • [23] Merkel cell carcinoma: What do we know about it and what should we do?
    Prieto Munoz, Isabel
    Pardo Masferrer, Jose
    Olivera Vegas, Jesus
    Fortes Alen, Jose Ramon
    Perez Casas, Ana M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (06) : 401 - 412
  • [24] Neighborhoods and Health: What Do We Know? What Should We Do?
    Roux, Ana V. Diez
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (03) : 430 - 431
  • [25] Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
    Guasch, E.
    Mont, L.
    Sitges, M.
    NETHERLANDS HEART JOURNAL, 2018, 26 (03) : 133 - 145
  • [26] Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?
    Askenazi, David J.
    Ambalavanan, Namasivayam
    Goldstein, Stuart L.
    PEDIATRIC NEPHROLOGY, 2009, 24 (02) : 265 - 274
  • [27] Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?
    David J. Askenazi
    Namasivayam Ambalavanan
    Stuart L. Goldstein
    Pediatric Nephrology, 2009, 24 : 265 - 274
  • [28] Pneumococcal conjugate vaccines: what do we know and what do we need?
    Schranz, Jennifer
    2ND GLOBAL CONGRESS ON VACCINES, 2009, 1 (01): : 189 - 205
  • [29] Implementing Exercise: What Do We Know? Where Do We Go?
    Painter, Patricia
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (06) : 536 - 544
  • [30] Do We Know What We Mean? An Examination of the Use of the Phrase "Goals of Care" in the Literature
    Edmonds, Kyle P.
    Ajayi, Toluwalase A.
    JOURNAL OF PALLIATIVE MEDICINE, 2019, 22 (12) : 1546 - 1552